Joshua R Heyza

Targeting the DNA Repair Endonuclease ERCC1-XPF with Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCG) and Its Prodrug to Enhance Cisplatin Efficacy in Human Cancer Cells

Q. Dou, S. Patrick, P. Erhardt, 2018, Nutrients.

Gap Junction Intercellular Communication Positively Regulates Cisplatin Toxicity by Inducing DNA Damage through Bystander Signaling

S. Patrick, R. Ruch, S. Arora, 2018, Cancers.

In Vivo Targeting Replication Protein A for Cancer Therapy

Navnath S. Gavande, S. Jalal, J. Turchi, 2022, Frontiers in Oncology.

Chemical exhaustion of RPA in cancer treatment

Navnath S. Gavande, S. Jalal, J. Turchi, 2020, bioRxiv.

ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe

G. Bepler, J. Turchi, A. Schwartz, 2023, NAR cancer.

Nanoparticle-Mediated Gene Silencing for Sensitization of Lung Cancer to Cisplatin Therapy

S. Patrick, O. Merkel, Daniel P Feldmann, 2020, Molecules.